In Vitro Metabolism of Pyranocoumarin Isomers Decursin and Decursinol Angelate by Liver Microsomes from Man and Rodents

Abstract

The aim of this study is to investigate and compare the metabolic rate and profiles of pyranocoumarin isomers decursin and decursinol angelate using liver microsomes from humans and rodents, and to characterize the major metabolites of decursin and decursinol angelate in human liver microsomal incubations using LC-MS/MS. First, we conducted liver microsomal incubations of decursin and decursinol angelate in the presence or absence of NADPH. We found that in the absence of NADPH, decursin was efficiently hydrolyzed to decursinol by hepatic esterase(s), but decursinol angelate was not. In contrast, formation of decursinol from decursinol angelate was mediated mainly by cytochrome P450(s). Second, we measured the metabolic rate of decursin and decursinol angelate in liver S9 fractions from mice and humans. We found that human liver S9 fractions metabolized both decursin and decursinol angelate more slowly than those of the mouse. Third, we characterized the major metabolites of decursin and decursinol angelate from human liver microsomes incubations using HPLC-UV and LC-MS/MS methods and assessed the in vivo metabolites in mouse plasma from a one-dose PK study. Decursin and decursinol angelate have different metabolite profiles. Nine metabolites of decursin and nine metabolites of decursinol angelate were identified in human liver microsome incubations besides decursinol using a hybrid triple quadruple linear ion trap LC-MS/MS system, and many of them were later verified to be also present in plasma samples from rodent PK studies.

Key words

decursin - decursinol angelate - decursinol - Angelica gigas Nakai - Apiaceae - LC-MS/MS - in vitro liver microsomal incubations

• References

• 1 Zhang J, Li L, Jiang C, Xing C, Kim SH, Lu J. Anti-cancer and other bioactivities of Korean Angelica gigas Nakai (AGN) and its major pyranocoumarin compounds. Anticancer Agents Med Chem 2012; 12: 1239-1254
• 2 Ahn MJ, Lee MK, Kim YC, Sung SH. The simultaneous determination of coumarins in Angelica gigas root by high performance liquid chromatography-diode array detector coupled with electrospray ionization/mass spectrometry. J Pharm Biomed Anal 2008; 46: 258-266
• 3 Lee HJ, Lee EO, Lee JH, Lee KS, Kim KH, Kim SH, Lu J. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. Am J Chin Med 2009; 37: 127-142
• 4 Lee S, Lee YS, Jung SH, Shin KH, Kim BK, Kang SS. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas . Arch Pharm Res 2003; 26: 727-730
• 5 Kang SY, Lee KY, Park MJ, Kim YC, Markelonis GJ, Oh TH. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice. Neurobiol Learn Mem 2003; 79: 11-18
• 6 Son SH, Park KK, Park SK, Kim YC, Kim YS, Lee SK, Chung WY. Decursin and decursinol from Angelica gigas inhibit the lung metastasis of murine colon carcinoma. Phytother Res 2011; 25: 959-964
• 7 Hwang JT, Kim SH, Hur HJ, Kim HJ, Park JH, Sung MJ, Yang HJ, Ryu SY, Kim YS, Cha MR, Kim MS, Kwon DY. Decursin, an active compound isolated from Angelica gigas, inhibits fat accumulation, reduces adipocytokine secretion and improves glucose tolerance in mice fed a high-fat diet. Phytother Res 2012; 26: 633-638
• 8 Li L, Zhang J, Shaik AA, Zhang Y, Wang L, Xing C, Kim SH, Lu J. Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC. Planta Med 2012; 78: 252-259
• 9 Park HS, Kim B, Oh JH, Kim YC, Lee YJ. First-pass metabolism of decursin, a bioactive compound of Angelica gigas, in rats. Planta Med 2012; 78: 909-913
• 10 Li L, Zhang J, Xing C, Kim SH, Lu J. Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats. Planta Med 2013; 79: 275-280
• 11 Sharma V, McNeill JH. To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol 2009; 157: 907-921
• 12 Guo J, Jiang C, Wang Z, Lee HJ, Hu H, Malewicz B, Lee JH, Baek NI, Jeong JH, Kim DK, Kang KS, Kim SH, Lu J. A novel class of pyranocoumarin anti-androgen receptor signaling compounds. Mol Cancer Ther 2007; 6: 907-917
• 13 Jiang C, Guo J, Wang Z, Xiao B, Lee HJ, Lee EO, Kim SH, Lu J. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells. Breast Cancer Res 2007; 9: R77
• 14 Zhang J, Li L, Zhang Y, Wang L, Jiang C, Kim S-H, Lü J. Proteomic and transcriptomic profiling of effects of Angelica gigas ethanol extract on prostate neuroendocrine carcinomas of TRAMP mice. Proc AACR 2012;
• 15 Jia L, Liu X. The conduct of drug metabolism studies considered good practice (II): in vitro experiments. Curr Drug Metab 2007; 8: 822-829
• 16 Li L, Li W, Jung SW, Lee YW, Kim YH. Protective effects of decursin and decursinol angelate against amyloid beta-protein-induced oxidative stress in the PC12 cell line: the role of Nrf2 and antioxidant enzymes. Biosci Biotechnol Biochem 2011; 75: 434-442
• 17 Yoo HH, Lee MW, Kim YC, Yun CH, Kim DH. Mechanism-based inactivation of cytochrome p 450 2A6 by decursinol angelate isolated from Angelica gigas . Drug Metab Dispos 2007; 35: 1759-1765
• 18 Kim KY, Lee S, Cha CJ. Biotransformation of plant secondary metabolite decursin by Mycobacterium sp. PYR1001. J Agric Food Chem 2010; 58: 2931-2934
• 19 Mahat B, Chae JW, Baek IH, Song GY, Song JS, Ma JY, Kwon KI. Biopharmaceutical characterization of decursin and their derivatives for drug discovery. Drug Dev Ind Pharm 2012; , eFirst September 25, 2012
• 20 Scollon EJ, Starr JM, Godin SJ, DeVito MJ, Hughes MF. In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome p 450 isoforms. Drug Metab Dispos 2009; 37: 221-228